These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7642566)

  • 1. Insulin-like growth factor I receptor activated by a transmembrane mutation.
    Takahashi K; Yonezawa K; Nishimoto I
    J Biol Chem; 1995 Aug; 270(32):19041-5. PubMed ID: 7642566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
    Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM; Teruel T; Lorenzo M; Benito M
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells.
    Amoui M; Craddock BP; Miller WT
    J Endocrinol; 2001 Oct; 171(1):153-62. PubMed ID: 11572799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase activity of a chimeric insulin-like-growth-factor-1 receptor containing the insulin receptor C-terminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growth-factor-1 receptors using a cell-free system.
    Mothe I; Tartare S; Kowalski-Chauvel A; Kaliman P; Van Obberghen E; Ballotti R
    Eur J Biochem; 1995 Mar; 228(3):842-8. PubMed ID: 7737184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
    Harada S; Smith RM; Smith JA; White MF; Jarett L
    J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
    Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
    Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.
    Fukushima T; Nakamura Y; Yamanaka D; Shibano T; Chida K; Minami S; Asano T; Hakuno F; Takahashi S
    J Biol Chem; 2012 Aug; 287(35):29713-21. PubMed ID: 22767591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
    Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
    J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
    Myers MG; Sun XJ; Cheatham B; Jachna BR; Glasheen EM; Backer JM; White MF
    Endocrinology; 1993 Apr; 132(4):1421-30. PubMed ID: 8384986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes.
    Kooijman R; Lauf JJ; Kappers AC; Rijkers GT
    J Exp Med; 1995 Aug; 182(2):593-7. PubMed ID: 7543144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
    Krause D; Lyons A; Fennelly C; O'Connor R
    J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
    Giorgino F; Smith RJ
    J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.
    Wilden PA; Broadway DE
    J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.